Together, these demonstrate that knockdown of Nrf1 leads to constitutive activation of β-catenin signaling pathway, and therefore results in a significant enhancement in the in vivo malgrowth of hepatoma and its malignant metastatic potentials. The gene discussed is NRF1; the disease is hepatocellular carcinoma.